resveratrol has been researched along with Carcinoma, Hepatocellular in 74 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.35) | 18.2507 |
| 2000's | 22 (29.73) | 29.6817 |
| 2010's | 32 (43.24) | 24.3611 |
| 2020's | 19 (25.68) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, Q; Guo, X; Lin, T; Liu, J; Wang, G; Xu, Y; Yao, X; Zeng, J; Zhang, XK | 1 |
| Coussons, PJ; D'Arcy, MS; Pike, CVS | 1 |
| El-Kamel, AH; El-Melegy, MG; Eltaher, HM; Gaballah, A | 1 |
| Berchtold, S; Burkard, M; Busch, C; Frank, J; Lauer, UM; Leischner, C; Marongiu, L; Michel, A; Niessner, H; Venturelli, S | 1 |
| Jia, R; Li, J; Qian, Y; Tian, X; Zheng, Y | 1 |
| Amiri, MS; Ghorani-Azam, A; Haddad-Mashadrizeh, A; Hashemzadeh, A; Iriti, M; Mashreghi, M; Mottaghipisheh, J; Nadaf, M; Nourbakhsh, F; Qayoomian, M; Taghavizadeh Yazdi, ME; Vitalini, S | 1 |
| Adamiec-Organisciok, M; Dziedzic, A; Filipec-Kanizaj, T; Grgurevic, I; Hudy, D; Jagodzinski, M; Kukla, M; Los, L; Nackiewicz, J; Skladany, L; Skonieczna, M | 1 |
| Azadbakht, O; Behrouj, H; Ghojoghi, R; Moghadam, D; Sabaghan, M; Vakili, S; Veisi, A; Zarei, R; Zarezade, V | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| ALkharashi, NA | 1 |
| Deng, J; Li, Z; Long, L; Luo, T; Peng, X; Wang, Y; Wang, Z; Zhang, H; Zhuo, L | 1 |
| Deng, J; Hao, L; Hu, X; Li, S; Zhang, J | 1 |
| Bajaj, S; Bansal, H; Fayaz, F; Kumar, S; Manchanda, S; Pottoo, FH | 1 |
| Chen, Y; Fu, S; Lu, Y; Luo, J; Wang, BQ; Wen, Q; Wu, J; Wu, Z; Xiong, K; Zhang, Y | 1 |
| Dai, H; Hu, X; Li, M; Su, J; Sun, X; Wang, P; Wang, X; Yang, W; Zhao, M | 1 |
| Chhonker, SK; Koiri, RK; Naik, RA; Rawat, D | 1 |
| Chen, Y; Dai, Z; Huang, H; Liang, CL; Liu, H; Qiu, F; Zhang, Q; Zheng, F | 1 |
| Afzal, O; Al-Abbasi, FA; Alenezi, SK; Alfawaz Altamimi, AS; Alhalmi, A; Almalki, WH; Barkat, MA; Beg, S; Choudhry, H; Kazmi, I; Kumar, V; Rahman, M | 1 |
| Bohara, R; Dhamecha, D; Jadhav, K; Jagwani, S; Jalalpure, S | 1 |
| Aishwarya, TS; Baby, J; Devan, AR; Gorantla, JN; Kumar, AR; Nair, B; Nath, LR | 1 |
| Chen, K; Chen, M; Li, J; Li, X; Wang, G; Wei, G; Yan, Y; Zhou, C | 1 |
| Abdel-Bar, HM; El Basset Sanad, RA | 1 |
| Damoiseaux, R; France, B; Gbadegesin, MA; Gimzewski, JK; Odunola, OA; Olugbami, JO; Onibiyo, EM; Sharma, S | 1 |
| Chai, R; Fu, H; Ji, S; Li, G; Liu, T; Zheng, Z | 1 |
| Hasegawa, K; Inagaki, Y; Rong, L; Sakamoto, Y; Sawakami, T; Song, P; Tang, W; Xia, J | 1 |
| Cai, W; Han, R; Huang, S; Li, M; Meng, Q; Wang, H; Wu, X; Yang, Z; Zhao, Y | 1 |
| Gao, Y; Li, Y; Liu, Z; Peng, Q | 1 |
| Anwar, DM; Bekhit, AA; Elkhodairy, KA; Elzoghby, AO; Helmy, MW; Kamal, MK; Khattab, SN | 1 |
| Sui, S; Yin, X; Zhang, B | 1 |
| Berk, K; Chabowski, A; Charytoniuk, T; Drygalski, K; Harasim-Symbor, E; Konstantynowicz-Nowicka, K; Polak, A | 1 |
| Huang, C; Li, Z; Zeng, J; Zhang, D; Zhang, J; Zhao, X; Zuo, H | 1 |
| Chen, TY; Chiou, HL; Hsieh, MJ; Lin, CW; Lin, PY; Yang, SF; Yeh, CB | 1 |
| Li, J; Li, Y; Liu, M; Wei, M; Zhu, W | 1 |
| Chen, Y; Cheng, X; He, Q; Ou, X; Zhang, X | 1 |
| Chen, CY; Li, WC; Ting, CT; Tsai, TH | 1 |
| Abudumijiti, H; Chen, K; Chen, R; Dai, W; Guo, C; He, L; Li, J; Li, S; Liu, T; Lu, J; Lu, W; Wang, C; Wang, F; Wang, J; Xia, Y; Xu, L; Yang, J; Yin, Q; Zhang, H; Zhang, R; Zheng, Y; Zhou, L; Zhou, Y; Zhou, Z; Zhu, R | 1 |
| Blasi, F; Cossignani, L; Dominici, L; Lombardi, G; Marcotullio, MC; Moretti, M; Vannini, S; Villarini, M | 1 |
| Heidor, R; Moreno, FS; Pogribny, IP | 1 |
| Bai, Y; Hao, L; Hu, W; Lv, Y; Ran, Y; Zhang, L | 1 |
| Deng, G; Gao, F; Li, M; Liu, W; Zhou, K | 1 |
| Li, T; Wang, W | 1 |
| Berry, DP; Dennison, AR; Garcea, G; Mann, CD; Manson, MM; Neal, CP | 1 |
| Cao, X; Chen, WQ; Du, LF; Fang, WY; Li, X; Marincola, FM; Stroncek, DF; Wang, E; Worschech, A; Xu, YY; Yang, HL | 1 |
| Choi, HJ; Fukui, M; Zhou, R; Zhu, BT | 1 |
| Bishayee, A; Booth, TD; Hodnichak, CM; Luther, DJ; Meszaros, JG; Ohanyan, V; Shamhart, PE; Sisakian, H | 1 |
| Bishayee, A; Darvesh, AS; Politis, T | 1 |
| Ho, CT; Huang, HW; Weng, CJ; Wu, CF; Wu, CH; Yen, GC | 1 |
| Khaoustov, V; Yoffe, B | 1 |
| Hamasaki, N; Hiroto, Y; Nakazono, E; Ohnaka, K; Tadokoro, K; Takayanagi, R; Tsuda, H; Tsuda, T | 1 |
| Liao, PC; Lin, CC; Lin, LT; Ng, LT; Richardson, CD; Wang, GH | 1 |
| Boesch-Saadatmandi, C; Breckwoldt, D; Döring, F; Hashida, K; Hori, O; Matsugo, S; Rimbach, G; Schmelzer, C; Schrader, C; Wagner, AE | 1 |
| Boylan, JM; Gruppuso, PA; Tatar, M; Villa-Cuesta, E | 1 |
| Chen, YF; Hsu, WH; Kao, CH; Lin, HC; Tsai, TF; Yang, CW | 1 |
| Deng, S; Du, Q; Hu, B; Shen, KP | 1 |
| Cho, IR; Chung, YH; Horio, Y; Jhun, BH; Koh, SS; Malilas, W; Moon, J; Srisuttee, R | 1 |
| Chiang, LC; Kuo, PL; Lin, CC | 1 |
| Liu, HS; Liu, XM; Pan, CE; Yang, W | 1 |
| Meng, KW; Pan, CE; Qin, XL; Sun, ZJ; Wu, SL; Yu, L | 1 |
| Barouki, R; Gouédard, C; Morel, Y | 1 |
| Miura, D; Miura, Y; Yagasaki, K | 1 |
| Brown, J; Le, AD; Lu, QY; Tang, X; Zhang, Q; Zhang, ZF | 1 |
| Chovolou, Y; Kahl, R; Kampkötter, A; Michels, G; Niering, P; Proksch, P; Wätjen, W; Weber, N | 1 |
| Ma, XD; Tian, XM; Yan, F | 1 |
| Cohen, RA; Hou, X; Jiang, B; Maitland-Toolan, KA; Verbeuren, TJ; Wierzbicki, M; Xu, S; Zang, M; Zuccollo, A | 1 |
| Gairola, CG; Puppala, D; Swanson, HI | 1 |
| Castanas, E; Kampa, M; Kouroumalis, E; Nifli, AP; Notas, G; Vercauteren, J | 1 |
| Bonnesen, C; Stervbo, U; Vang, O | 1 |
| Artur, Y; Chagnon, MC; Delmas, D; Hanet, N; Heydel, JM; Jannin, B; Lançon, A; Latruffe, N; Lizard, G | 1 |
| Kocsis, Z; Marcsek, ZL; Szende, B; Tompa, A | 1 |
| Pan, CE; Wu, WJ; Yu, HB; Zhang, HF; Zhao, SH | 1 |
| Ciolino, HP; Daschner, PJ; Yeh, GC | 1 |
| Kozuki, Y; Miura, Y; Yagasaki, K | 1 |
| Bedin, C; Bioulac-Sage, P; De Lédinghen, V; Desmoulière, A; Krisa, S; Monvoisin, A; Neaud, V; Payrastre, B; Rosenbaum, J | 1 |
| Liu, HS; Pan, CE; Sun, ZJ; Wang, GJ | 1 |
7 review(s) available for resveratrol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Nanophytomedicine Based Novel Therapeutic Strategies in Liver Cancer.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Catechin; Curcumin; Drug Compounding; Drug Stability; Humans; Liver Neoplasms; Nanocapsules; Plant Extracts; Quercetin; Resveratrol; Solubility; Theranostic Nanomedicine | 2020 |
Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review.
Topics: Carcinoma, Hepatocellular; Chemoprevention; Flavonoids; Humans; Liver Neoplasms; Resveratrol | 2021 |
Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.
Topics: Abietanes; Benzylisoquinolines; Berberine; Carcinoma, Hepatocellular; Curcumin; Drugs, Chinese Herbal; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Resveratrol; Scutellaria baicalensis; Stilbenes | 2015 |
Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents.
Topics: Animals; Butyric Acid; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Curcumin; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; Food; Humans; Isothiocyanates; Phytochemicals; Resveratrol; Stilbenes; Sulfoxides | 2016 |
Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brassicaceae; Caffeine; Capsaicin; Carcinoma, Hepatocellular; Catechin; Chemoprevention; Curcumin; Flavonoids; Humans; Liver Neoplasms; Phenols; Plant Extracts; Polyphenols; Resveratrol; Stilbenes | 2009 |
Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Resveratrol; Stilbenes | 2010 |
1 trial(s) available for resveratrol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
67 other study(ies) available for resveratrol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
A resveratrol analog, phoyunbene B, induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; M Phase Cell Cycle Checkpoints; Orchidaceae; Resveratrol; Stilbenes | 2012 |
A novel combined resveratrol/berberine phytochemotheraputic using the HePG2 cell line as a model for the treatment of hepatocarcinoma.
Topics: Apoptosis; Berberine; Carcinoma, Hepatocellular; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Hep G2 Cells; Humans; Liver Neoplasms; Protein Glutamine gamma Glutamyltransferase 2; Resveratrol | 2021 |
Enhanced oral permeability of Trans-Resveratrol using nanocochleates for boosting anticancer efficacy; in-vitro and ex-vivo appraisal.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Caco-2 Cells; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Male; Nanoparticles; Particle Size; Rats; Rats, Wistar; Resveratrol; Solubility | 2021 |
Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Resveratrol; Tumor Suppressor Protein p53 | 2021 |
Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Curcumin; Drug Carriers; Humans; Liver Neoplasms; Nanoparticles; Resveratrol | 2022 |
Resveratrol-Mediated Gold-Nanoceria Synthesis as Green Nanomedicine for Phytotherapy of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cerium; Gold; Humans; Liver Neoplasms; Metal Nanoparticles; Nanomedicine; Phytotherapy; Resveratrol | 2022 |
Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine.
Topics: Apoptosis; Berberine; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Humans; Liver Neoplasms; Resveratrol; Tumor Suppressor Protein p53 | 2022 |
The effect of natural polyphenols Resveratrol, Gallic acid, and Kuromanin chloride on human telomerase reverse transcriptase (hTERT) expression in HepG2 hepatocellular carcinoma: role of SIRT1/Nrf2 signaling pathway and oxidative stress.
Topics: Carcinoma, Hepatocellular; Chlorides; Gallic Acid; Humans; Liver Neoplasms; NF-E2-Related Factor 2; Oxidative Stress; Polyphenols; Resveratrol; Signal Transduction; Sirtuin 1; Telomerase | 2023 |
Efficacy of resveratrol against breast cancer and hepatocellular carcinoma cell lines.
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Female; Humans; Liver Neoplasms; Resveratrol | 2023 |
Design, synthesis, and biological evaluation of 1-styrenyl isoquinoline derivatives for anti-hepatocellular carcinoma activity and effect on mitochondria.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Isoquinolines; Liver Neoplasms; Mice; Mitochondria; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol | 2023 |
Coptidis rhizoma and evodiae fructus against lipid droplet deposition in nonalcoholic fatty liver disease-related liver cancer by AKT.
Topics: Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Evodia; Humans; Lipid Droplets; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Proto-Oncogene Proteins c-akt; Quercetin; Resveratrol | 2023 |
Therapeutic efficacy of thermosensitive Pluronic hydrogel for codelivery of resveratrol microspheres and cisplatin in the treatment of liver cancer ascites.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Hepatocellular; Cisplatin; Drug Carriers; Drug Compounding; Drug Liberation; Female; Hep G2 Cells; Humans; Hydrogels; Kinetics; Liver Neoplasms; Mice; Microspheres; Poloxamer; Resveratrol; Stimuli Responsive Polymers; Temperature | 2020 |
Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling.
Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; RNA, Small Interfering; Signal Transduction; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2020 |
Modulation of antioxidant enzymes, SIRT1 and NF-κB by resveratrol and nicotinamide in alcohol-aflatoxin B1-induced hepatocellular carcinoma.
Topics: Aflatoxin B1; Animals; Antioxidants; Carcinoma, Hepatocellular; Ethanol; Liver Neoplasms, Experimental; Male; Neoplasm Proteins; NF-kappa B; Niacinamide; Rats; Resveratrol; Sirtuin 1 | 2021 |
Resveratrol exerts antitumor effects by downregulating CD8
Topics: Animals; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Liver Neoplasms; Mice; Resveratrol; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2020 |
Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation.
Topics: Animals; Antioxidants; Body Weight; Carcinoma, Hepatocellular; Cations; Cell Death; Drug Carriers; Drug Liberation; Inflammation Mediators; Lipids; Liver; Liver Neoplasms; Male; Nanoparticles; Organ Size; Particle Size; Rats, Wistar; Resveratrol; Static Electricity; Tissue Distribution; Tumor Burden | 2020 |
Pharmacokinetic and Pharmacodynamic Evaluation of Resveratrol Loaded Cationic Liposomes for Targeting Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Liposomes; Liver Neoplasms; Particle Size; Rats; Resveratrol | 2020 |
Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1.
Topics: Carcinoma, Hepatocellular; Disease Progression; Hep G2 Cells; Hepatic Stellate Cells; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Liver Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A; Zinc Finger Protein GLI1 | 2017 |
Endocytic pathways of optimized resveratrol cubosomes capturing into human hepatoma cells.
Topics: Carcinoma, Hepatocellular; Endocytosis; Hep G2 Cells; Humans; Liquid Crystals; Liver Neoplasms; Nanoparticles; Particle Size; Resveratrol; Solubility; Stilbenes | 2017 |
A comparative assessment of antiproliferative properties of resveratrol and ethanol leaf extract of Anogeissus leiocarpus (DC) Guill and Perr against HepG2 hepatocarcinoma cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Proliferation; Combretaceae; Flavonoids; Hep G2 Cells; Humans; Liver Neoplasms; Mitochondria; Necrosis; Phenols; Phytotherapy; Plant Extracts; Plant Leaves; Resveratrol; Stilbenes | 2017 |
Resveratrol inhibits proliferation and migration through SIRT1 mediated post‑translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Doxorubicin; Drugs, Chinese Herbal; Hep G2 Cells; Humans; Liver Neoplasms; Neoplasm Invasiveness; Quercetin; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction; Stilbenes | 2018 |
Resveratrol Promoted Interferon-α-Induced Growth Inhibition and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Interferon-alpha; Liver Neoplasms; Resveratrol; Signal Transduction; Sirtuins; STAT1 Transcription Factor | 2018 |
Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition.
Topics: Amino Acid Transport System ASC; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cisplatin; Down-Regulation; Drug Screening Assays, Antitumor; Flow Cytometry; Glutamine; Humans; Liver Neoplasms; Minor Histocompatibility Antigens; Reactive Oxygen Species; Resveratrol; Tumor Cells, Cultured | 2018 |
Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disaccharides; Drug Delivery Systems; Folic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Micelles; Polysaccharides; Resveratrol; Sulfasalazine; Xenograft Model Antitumor Assays | 2018 |
Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway.
Topics: Adenine; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzothiazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Toluene; Tumor Suppressor Protein p53; Up-Regulation | 2018 |
Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State.
Topics: Carcinoma, Hepatocellular; Caspase 3; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Lipid Metabolism; Liver Neoplasms; Palmitic Acid; Protective Agents; Resveratrol; Sphingolipids; Structure-Activity Relationship; Triglycerides; Tumor Cells, Cultured | 2019 |
Nano-Gold Loaded with Resveratrol Enhance the Anti-Hepatoma Effect of Resveratrol
Topics: Apoptosis; Carcinoma, Hepatocellular; Gold; Humans; Liver Neoplasms; Metal Nanoparticles; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2019 |
The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Invasiveness; Phosphorylation; Resveratrol; Signal Transduction; Sp1 Transcription Factor; Stilbenes; Urokinase-Type Plasminogen Activator | 2013 |
Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Diabetes Mellitus, Type 2; Gene Expression Regulation, Neoplastic; Glucose; Hep G2 Cells; Humans; Liver Neoplasms; Resveratrol; RNA, Small Interfering; Signal Transduction; Sirtuin 1; STAT3 Transcription Factor; Stilbenes | 2013 |
Potentiation of resveratrol-induced apoptosis by matrine in human hepatoma HepG2 cells.
Topics: Alkaloids; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Matrines; Proto-Oncogene Proteins c-bcl-2; Quinolizines; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2014 |
By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.
Topics: Aerobiosis; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Growth Processes; Cell Line, Tumor; Glycolysis; Hep G2 Cells; Hexokinase; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Random Allocation; Resveratrol; Stilbenes | 2015 |
In Vitro Safety/Protection Assessment of Resveratrol and Pterostilbene in a Human Hepatoma Cell Line (HepG2).
Topics: Apoptosis; Carcinoma, Hepatocellular; DNA Damage; Hep G2 Cells; Humans; Liver Neoplasms; Protective Agents; Resveratrol; Stilbenes | 2015 |
Novel multifunctional pH-sensitive nanoparticles loaded into microbubbles as drug delivery vehicles for enhanced tumor targeting.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Hydrogen-Ion Concentration; Mice; Microbubbles; Molecular Targeted Therapy; Nanoparticles; Neoplasm Transplantation; Neoplasms; Resveratrol; Stilbenes; Treatment Outcome | 2016 |
Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Knockdown Techniques; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Mice, Nude; Molecular Targeted Therapy; Phosphorylation; Proto-Oncogene Proteins c-met; Resveratrol; Signal Transduction; Stilbenes; Xenograft Model Antitumor Assays | 2017 |
[The mechanism of resveratrol on anti-hepatoma Bel-7402 and modulating IL-8 in tumor model mice].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Flow Cytometry; Interleukin-8; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes | 2008 |
Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Hepatocellular; Caveolin 1; Cell Death; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Drug Synergism; Endocytosis; Genes, Reporter; Humans; Liver Neoplasms; Mice; Mice, Nude; Resveratrol; Sequence Deletion; Stilbenes; Transfection | 2009 |
Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; DNA; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Resveratrol; S Phase; Signal Transduction; Stilbenes | 2009 |
Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.
Topics: Animals; Behavior, Animal; Blotting, Western; Carcinoma, Hepatocellular; Cardiotoxins; Chemoprevention; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography; Feeding Behavior; Female; Heart; Hepatocytes; Humans; Liver; Liver Neoplasms; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Systole | 2011 |
Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Neoplasm Invasiveness; Resveratrol; Stilbenes | 2010 |
Identification of components of grape powder with anti-apoptotic effects.
Topics: Anthocyanins; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Catechin; Cell Death; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum; Food, Preserved; Freeze Drying; Fruit; Humans; Liver Neoplasms; Mitochondria, Liver; Oxidative Stress; Quercetin; Reactive Oxygen Species; Resveratrol; Stilbenes; Taurodeoxycholic Acid; Vitis | 2011 |
Resveratrol, a phytoestrogen found in red wine, down-regulates protein S expression in HepG2 cells.
Topics: Blood Proteins; Blotting, Western; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Estrogen Receptor alpha; Gene Expression Regulation, Neoplastic; Genistein; Hep G2 Cells; Histocompatibility Antigens; Humans; Liver Neoplasms; Molecular Structure; Phytoestrogens; Promoter Regions, Genetic; Protein C; Protein S; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Structure-Activity Relationship; Time Factors; Transcription, Genetic; Transfection; Wine | 2011 |
Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Down-Regulation; Humans; Inhibitory Concentration 50; Liver Neoplasms; MAP Kinase Signaling System; Resveratrol; S Phase; Stilbenes; Time Factors; Up-Regulation | 2010 |
Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes - role of the redox-regulated transcription factor Nrf2.
Topics: Antioxidants; Aryldialkylphosphatase; Ascorbic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Interactions; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Hepatocytes; Humans; Hydrogen Peroxide; NF-E2-Related Factor 2; Plant Extracts; Resveratrol; RNA, Messenger; Stilbenes; Transcriptional Activation | 2011 |
Resveratrol inhibits protein translation in hepatic cells.
Topics: AMP-Activated Protein Kinases; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Enzyme Activation; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4F; Liver; Liver Neoplasms; Phosphorylation; Protein Biosynthesis; Protein Kinase Inhibitors; Protein Stability; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Signal Transduction; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Transcription Factors | 2011 |
Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Hepatocellular; Disease Models, Animal; Fatty Liver; Glutathione; Humans; Immunoenzyme Techniques; Liver Neoplasms, Experimental; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Trans-Activators; Tumor Cells, Cultured; Viral Regulatory and Accessory Proteins | 2012 |
[Effects of resveratrol on apoptosis and ROS production in Hepa 1-6 hepatocarcinoma cells].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Liver Neoplasms; Mice; Plants, Medicinal; Reactive Oxygen Species; Resveratrol; Stilbenes | 2012 |
SIRT1 sensitizes hepatocellular carcinoma cells expressing hepatitis B virus X protein to oxidative stress-induced apoptosis.
Topics: Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Nucleus; Humans; Liver Neoplasms; MAP Kinase Kinase 4; Oxidative Stress; Phosphorylation; Resveratrol; RNA, Small Interfering; Sirtuin 1; Stilbenes; Trans-Activators; Up-Regulation; Viral Regulatory and Accessory Proteins | 2012 |
Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; fas Receptor; Growth Inhibitors; Humans; Kinetics; Liver Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice.
Topics: Adjuvants, Immunologic; Animals; Antibody-Producing Cells; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Erythrocytes; Immunoglobulin G; Liver Neoplasms, Experimental; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Resveratrol; Sheep; Stilbenes; Tumor Necrosis Factor-alpha | 2003 |
Effect of resveratrol and in combination with 5-FU on murine liver cancer.
Topics: Animals; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Cell Cycle Proteins; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Resveratrol; Stilbenes; Survival Rate | 2004 |
Induction of the paraoxonase-1 gene expression by resveratrol.
Topics: Aryldialkylphosphatase; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Chromosome Mapping; Enzyme Induction; Estrogen Receptor alpha; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Liver Neoplasms; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Response Elements; Resveratrol; Stilbenes; Transcriptional Activation; Transfection; Xenobiotics | 2004 |
Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property.
Topics: Animals; Carcinoma, Hepatocellular; Free Radical Scavengers; Gene Expression; Hepatocyte Growth Factor; Hypoxanthine; Liver Neoplasms; Male; Neoplasm Invasiveness; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Cells, Cultured; Xanthine Oxidase | 2004 |
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resveratrol; RNA, Messenger; Stilbenes; Tongue Neoplasms; Transcriptional Activation; Vascular Endothelial Growth Factors | 2005 |
Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Line; Cell Survival; Comet Assay; DNA Damage; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Necrosis; Rats; Resveratrol; Stilbenes | 2006 |
[Effects of resveratrol on growth inhibition and gap-junctional intercellular communication of HepG2 cells].
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Communication; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gap Junctions; Humans; Liver Neoplasms; Resveratrol; S Phase; Stilbenes | 2006 |
Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Apigenin; Atherosclerosis; Benzopyrans; Carcinoma, Hepatocellular; Cell Line, Tumor; Diabetes Mellitus, Experimental; Enzyme Activation; Flavonoids; Glucose; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipids; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Multienzyme Complexes; Phenols; Phosphorylation; Polyphenols; Protein Serine-Threonine Kinases; Receptors, LDL; Resveratrol; Stilbenes | 2006 |
Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Transformation, Neoplastic; Dimethyl Sulfoxide; Flavanones; Flavones; Flavonoids; Humans; Kaempferols; Liver Transplantation; Luteolin; Receptors, Aryl Hydrocarbon; Resveratrol; Smoking; Stilbenes | 2007 |
Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; G1 Phase; G2 Phase; Humans; Liver Neoplasms; Nitric Oxide; Nitric Oxide Synthase; Reactive Oxygen Species; Resveratrol; Stilbenes; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 2006 |
Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells.
Topics: Annexin A5; Anticarcinogenic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Nucleus Size; DNA Fragmentation; Dose-Response Relationship, Drug; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Resveratrol; Stilbenes; Thymidine; Tritium | 2006 |
Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromatography, High Pressure Liquid; Enzyme Induction; Enzymes; Flow Cytometry; Glucuronosyltransferase; Humans; Liver Neoplasms; Mass Spectrometry; Metabolic Detoxication, Phase II; Multidrug Resistance-Associated Proteins; Propionates; Quinolines; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Sulfotransferases; Time Factors; Tritium | 2007 |
Effect of formaldehyde and resveratrol on the viability of Vero, HepG2 and MCF-7 cells.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Disinfectants; Formaldehyde; Liver Neoplasms; Receptors, Estrogen; Resveratrol; Stilbenes; Vero Cells | 2007 |
[Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells].
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; Resveratrol; RNA, Messenger; Stilbenes; Tumor Cells, Cultured | 2008 |
Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cytochrome P-450 CYP1A1; Cytosol; Humans; Liver Neoplasms; Polychlorinated Dibenzodioxins; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Resveratrol; RNA, Messenger; Stilbenes; Tumor Cells, Cultured | 1998 |
Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action.
Topics: Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Hepatocellular; Cell Division; Hypoxanthine; Liver Neoplasms; Neoplasm Invasiveness; Rats; Resveratrol; Stilbenes; Tumor Cells, Cultured; Xanthine Oxidase | 2001 |
Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Division; Cell Survival; Flavonoids; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Phenols; Phosphorylation; Poly(ADP-ribose) Polymerases; Polymers; Polyphenols; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Resveratrol; RNA, Messenger; Stilbenes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2001 |
Anti-hepatoma activity of resveratrol in vitro.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Humans; In Vitro Techniques; Liver Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2002 |